News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,981 Results
Type
Article (39021)
Company Profile (279)
Press Release (645681)
Section
Business (203855)
Career Advice (1988)
Deals (35361)
Drug Delivery (85)
Drug Development (80785)
Employer Resources (168)
FDA (16086)
Job Trends (14802)
News (344517)
Policy (32433)
Tag
Academia (2530)
Alliances (49061)
Alzheimer's disease (1225)
Approvals (16013)
Artificial intelligence (125)
Bankruptcy (352)
Best Places to Work (11528)
Biotechnology (200)
Breast cancer (116)
Cancer (1031)
Cardiovascular disease (86)
Career advice (1658)
Cell therapy (220)
Clinical research (64123)
Collaboration (365)
Compensation (188)
COVID-19 (2528)
C-suite (87)
Data (1041)
Diabetes (150)
Diagnostics (6131)
Earnings (84795)
Employer resources (146)
Events (109340)
Executive appointments (279)
FDA (16591)
Funding (329)
Gene therapy (170)
GLP-1 (572)
Government (4322)
Healthcare (18663)
Infectious disease (2610)
Inflammatory bowel disease (104)
Interviews (308)
IPO (16284)
Job creations (3623)
Job search strategy (1416)
Layoffs (412)
Legal (7851)
Lung cancer (165)
Manufacturing (170)
Medical device (13169)
Medtech (13174)
Mergers & acquisitions (19135)
Metabolic disorders (390)
Neuroscience (1481)
NextGen Class of 2024 (6499)
Non-profit (4463)
Northern California (1413)
Obesity (226)
Opinion (178)
Patents (98)
People (56204)
Phase I (19907)
Phase II (28241)
Phase III (21063)
Pipeline (441)
Postmarket research (2553)
Preclinical (8471)
Radiopharmaceuticals (234)
Rare diseases (206)
Real estate (5889)
Regulatory (21493)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1261)
Startups (3560)
United States (13007)
Vaccines (547)
Weight loss (165)
Date
Last 7 days (919)
Last 30 days (3407)
Last 365 days (35388)
2024 (32087)
2023 (40074)
2022 (51174)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (190)
Asia (37083)
Australia (6050)
California (3182)
Canada (1254)
China (237)
Colorado (142)
Connecticut (143)
Europe (79423)
Florida (438)
Georgia (112)
Illinois (336)
Indiana (190)
Kansas (96)
Maryland (567)
Massachusetts (2520)
Michigan (153)
Minnesota (268)
New Jersey (920)
New York (926)
North Carolina (689)
Northern California (1413)
Ohio (133)
Pennsylvania (815)
South America (1091)
Southern California (1261)
Texas (435)
Utah (88)
Washington State (351)
684,981 Results for "genedit inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology
November 13, 2024
·
3 min read
Business
GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease
GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy® platform for tissue-selective delivery, today announced a multiyear collaboration and license agreement with Genentech, a member of the Roche Group.
January 23, 2024
·
2 min read
Biotech Bay
GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021
GenEdit, Inc today announced that it has closed a $26 million Series A financing.
September 23, 2021
·
3 min read
Business
Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases
Sarepta and GenEdit will work together to identify development candidates for further testing.
February 1, 2022
·
7 min read
Business
GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials
GenEdit, Inc., a biotechnology company with a mission to develop curative therapies through targeted in vivo delivery of genetic medicines, announced that it has added two accomplished industry executives to its leadership team.
September 22, 2021
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Biotech Bay
GenEdit Uncloaks to Solve Gene Editing “Delivery Problem”
Kunwoo Lee has uncloaked his solution to the gene-editing “delivery problem” with $26 million in Series A funds for his company, GenEdit.
September 23, 2021
·
3 min read
·
Kate Goodwin
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
Progyny, Inc. to Present at Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
1 of 68,499
Next
